Envista is a global dental products company that makes and sells products used by dental professionals across the full range of a dental practice's needs — from imaging equipment to implants, aligners, and everyday consumables. Envista operates two segments: Specialty Products & Technologies (~64% of revenue), which includes dental implants and orthodontic products, and Equipment & Consumables (~36%), which includes imaging systems and everyday dental supplies. Key brands include Nobel Biocare and Implant Direct for implants, Spark for clear aligners, Ormco and Damon for orthodontic brackets and wires, DEXIS and i-CAT for dental imaging, and Kerr and Metrex for consumables. Envista sells specialty products like implants and aligners largely direct through its own commercial salesforce, while consumables and equipment move primarily through third-party distributors, with Henry Schein accounting for roughly 12% of total sales. The business model benefits from a high mix of recurring, consumable-natured revenue — implant components and aligner cases are consumed with each patient procedure, while everyday dental supplies track patient visit volume. Envista generates roughly 22% of sales from emerging markets, which it views as a long-term growth engine given low dental penetration rates. China (~7% of sales) is a key market, though ongoing volume-based procurement reforms are driving mandated price cuts across implants and orthodontics. Spark, Envista's clear aligner brand launched in 2019, reached nearly $300M in revenue and turned operating profit positive in 2025, driven by manufacturing automation and unit cost reductions.